
Journal of Huntington s Disease, Journal Year: 2025, Volume and Issue: unknown
Published: March 28, 2025
Microglia, the resident immune cells of central nervous system, play a pivotal role in response to Huntington's disease (HD) pathology. Through both cell-autonomous mechanisms and exposure external pathogenic stimuli, microglia transition from resting an activated state, producing pro-inflammatory cytokines chemokines that mediate inflammation. While this inflammatory attempts have neuroprotective compensatory effect, chronic microglial activation exacerbates neuroinflammation, neurodegeneration contributes progression. Evidence postmortem analyses neuroimaging studies indicates are present various stages HD, correlating with neuronal degeneration clinical symptoms. Enhanced has been identified as early predictor onset, particularly premanifest highlighting potential targeting pathways for therapeutic interventions. This review explores microglia's dual HD pathophysiology, exploring their contributions neuroinflammation neuroprotection. It also examines recent advances trials aimed at modulating activity, paving way novel strategies alter progression improve patient outcomes.
Language: Английский